Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether medicated intravenous fluids used for sugar, electrolyte or fluid replenishment remained exempt under Notification No. 3/2001-C.E. despite the 2001-2002 budget restriction and the addition of medicaments making them Schedule H drugs; (ii) Whether the Tribunal erred in refusing additional evidence sought to be produced by the assessee.
Issue (i): Whether medicated intravenous fluids used for sugar, electrolyte or fluid replenishment remained exempt under Notification No. 3/2001-C.E. despite the 2001-2002 budget restriction and the addition of medicaments making them Schedule H drugs.
Analysis: The exemption was confined to intravenous fluids used for sugar, electrolyte or fluid replenishment. The later budget clarification and the amended notification showed that the exemption was intended only for such fluids and not for intravenous fluids that had been medicated and acquired a separate therapeutic character. Once medicaments were added and the products were labelled as Schedule H drugs, their use was no longer confined to the exempted category. Exemption notifications are to be construed strictly and the assessee had to establish that the goods fell squarely within the notification.
Conclusion: The medicated intravenous fluids did not qualify for exemption and the finding was against the assessee.
Issue (ii): Whether the Tribunal erred in refusing additional evidence sought to be produced by the assessee.
Analysis: The Tribunal recorded that the material sought to be introduced did not relate to the issue under consideration and that the matter could be decided on the evidence already on record. No prejudice from the refusal of additional evidence was shown, and the refusal was consistent with the limited scope of the remand.
Conclusion: The refusal to admit additional evidence was upheld and was against the assessee.
Final Conclusion: The appeal failed on both the exemption issue and the evidentiary issue, and the demand confirmed by the authorities was sustained.
Ratio Decidendi: A medicated intravenous fluid that acquires the character of a Schedule H drug and is no longer confined to sugar, electrolyte or fluid replenishment falls outside a strictly construed exemption notification; refusal of additional evidence will not be interfered with where the material is unrelated to the remanded issue and no prejudice is shown.